Numerous enzymes use a variety of cofactors for achieving their impressive catalytic prowess. Generally, these cofactors are generated via complex multistep biosynthetic pathways involving many proteins. A less commonly encountered means of cofactor biosynthesis, but one that is found with increasing frequency, involves the posttranslational modification of endogenous amino acids in the enzyme. These modifications can occur via autocatalytic processes or may be catalyzed by other auxiliary proteins. In this issue, Firbank et al. describe the crystal structure of the precursor of galactose oxidase (GAO), a self-processing enzyme that generates a crosslink between a cysteine and a tyrosine (1). The one-electron oxidized form of this crosslink (a crosslinked tyrosyl radical) functions as the cofactor in the oxidation of primary alcohols. The current work provides an important foundation to study the mechanism of autocatalytic cofactor generation in GAO and may also provide insights into the biogenesis of crosslinked cofactors found in other proteins (2).
A growing number of enzymes have been reported that undergo posttranslational modifications of amino acids within their active sites to create a wide variety of structurally and functionally diverse cofactors. These modifications can be divided into two general classes. One involves proteins that undergo one-electron oxidations of amino acids to provide amino acid radicals on tyrosine, glycine, tryptophan, and cysteine residues (3). The second class undergoes more extensive posttranslational modifications that involve new bond-forming reactions (2). Tyrosines are the most frequently modified residues in this group and are transformed into a wide variety of novel structures (Fig. 1). Amine oxidases and lysyl oxidase contain the quinone cofactors 2,4,5-trihydroxyphenylalanine quinone (TPQ) and lysyl tyrosylquinone (LTQ), respectively (4, 5). The terminal electron transport protein cytochrome c oxidase (CcO) is posttranslationally modified through a crosslink between histidine and tyrosine in both bacteria (6) and mammals (7). His and Tyr residues are also crosslinked in catalase HPII from Escherichia coli, but the linkage in this protein involves a bond between the Cβ of tyrosine and Nδ of histidine (8). In galactose oxidase, as well as glyoxal oxidase, a tyrosine residue is crosslinked by a thioether bond between Cɛ of the aromatic ring and the sulfur atom of a cysteine (9). This crosslinked tyrosine serves as a ligand to a catalytically essential copper and is oxidized to the tyrosyl radical form in the active state of the protein (10, 11).
The Cu(II)/Cys-Tyr⋅ cofactor in GAO carries out a two-electron oxidation of primary alcohols to the corresponding aldehydes via a radical mechanism (Fig. 2). It is generally agreed upon that the Cys-Tyr⋅ cofactor abstracts a hydrogen atom from the substrate bound to copper. Less clear is the actual role of the crosslink. Initial studies on model compounds noticed the lowering of the one-electron oxidation potential of phenols substituted with a thioether in the ortho position (12). This lowered potential nicely correlated with the enormous decrease in the oxidation potential of the Tyr-Cys crosslink from ≈1 V for regular tyrosines to 0.4 V in GAO (13). Whereas these reports suggested an electronic role for the crosslink, several other studies have presented support against this hypothesis with DFT calculations predicting only a 1.7 kcal/mol stabilization of the radical because of the crosslink (14). These results have been interpreted to indicate a structural role of the thioether bridge.
The discovery of posttranslationally modified endogenous cofactors has led to great interest into the mechanisms of their formation. Some of these structures, such as tryptophan tryptophyl quinone (TTQ) in methylamine dehydrogenase (15) and formylglycine in sulfatases (16) are generated by accessory proteins (Fig. 3). Others, on the other hand, including TPQ (Fig. 1; refs. 17–19), the MIO structure in phenylalanine ammonia lyase (20), and the chromophore in green fluorescent protein (21) are produced by autocatalytic processes (Fig. 3). Unique among this latter group is galactose oxidase because its self-catalytic maturation involves two very different reactions, the cleavage of a 17-amino acid N-terminal pro-sequence as well as the three-electron oxidation of a Tyr and Cys to the Cys-Tyr⋅ cofactor. Dooley and coworkers previously showed that both reactions do not proceed when the protein is heterologously expressed and purified under strictly metal-free conditions (22). On aerobic incubation of this apo-pro-enzyme with copper, the mature active form of GAO was formed. In this issue, Firbank et al. follow up on this interesting finding with the determination of the three-dimensional structure of the apo-pro-enzyme (1). The presence of the N-terminal pro-sequence leads to changes in five regions compared with the mature protein. The pro-peptide does not make direct contact with the active site, but prevents several strands and loops to reside at the positions they occupy in the processed protein. As a result, the two residues to be crosslinked, Tyr-272 and Cys-228, as well as Trp-290 that π-stacks with the crosslink once formed (Fig. 4A), are in very different positions in the pro-enzyme. The remaining copper ligands, however, are in similar orientations and positions as in the mature protein, suggesting that the pro-enzyme may bind copper at the site to initiate the posttranslational modification events. At least one other protein generates its cofactor by posttranslational modification involving an autocatalytic cleavage of a peptide bond. Histidine decarboxylase is composed of two subunits that originate from the self-processing of an inactive pro-enzyme. During the autocatalytic cleavage, an essential pyruvoyl group is formed at the amino terminus of the α-subunit that derives from Ser-82 of the pro-enzyme (23). In GAO, however, cleavage of the pro-sequence and formation of the cofactor must be separate processes because an intermediate form lacking the N-terminal pro-peptide but without the crosslink has been identified (22). This observation suggests that the mechanisms of both modifications may be elucidated in future investigations.
Interestingly, the authors show that part of Cys-228 may be present in the form of a sulfenate, and they suggest an interesting new proposal for crosslink formation that involves attack by the tyrosine onto an electrophilic sulfur. In this scenario, copper might play a role in both the oxidation of the cysteine and cleavage of the S–O bond of the sulfenate. Sulfenates and sulfinates are present in a number of other proteins, including nitrile hydratase (24), NADH peroxidase, and peroxiredoxins (25). In nitrile hydratase, their formation from cysteine is also likely metal promoted given they are ligands to the catalytically active iron (Fig. 4D). Metals are in fact located close to all posttranslationally modified tyrosines in Fig. 1 (see Fig. 4). In amine oxidases, oxygen and copper are essential and sufficient for TPQ formation from apo-enzyme (17–19). The copper has been shown to activate the tyrosine for reaction with oxygen (19, 26, 27), and a similar role of the copper can be proposed for the initial oxidation of the tyrosine in GAO (1). The mechanism of formation of the His–Tyr crosslink in cytochrome c oxidase is not known, but it is likely that the metals in the bimetallic center will be involved (Fig. 4C).
The original reports on the crosslinked tyrosyl radical liganded to Cu(II) led to an explosion in efforts toward development of biomimetic models of the GAO active site and its catalytic properties. These studies have been exceptionally successful, leading to reproduction of the structure, spectroscopy, and catalytic activity of the copper site with low molecular weight copper complexes (28–30). The determination of the structure of unprocessed galactose oxidase reported in this issue may spur similar efforts in trying to understand the mechanism of the formation of the Cu(II)-Cys-Tyr⋅ cofactor, both in GAO itself and in model systems and designed proteins.
Acknowledgments
We thank Nicole Okeley for help in preparing Fig. 4. Our work on posttranslational modifications is supported by grants from the Burroughs–Wellcome Fund (APP 1920) and the National Institutes of Health (GM58822). W.A.v.d.D. is a Cottrell Scholar of the Research Corporation.
Footnotes
See companion article on page 12932.
References
- 1.Firbank S J, Rogers M S, Wilmot C M, Dooley D M, Halcrow M A, Knowles P F, McPherson M J, Phillips S E V. Proc Natl Acad Sci USA. 2001;98:12932–12937. doi: 10.1073/pnas.231463798. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Okeley N M, van der Donk W A. Chem Biol. 2000;7:R159–R171. doi: 10.1016/s1074-5521(00)00140-x. [DOI] [PubMed] [Google Scholar]
- 3.Stubbe J, van der Donk W A. Chem Rev. 1998;98:705–762. doi: 10.1021/cr9400875. [DOI] [PubMed] [Google Scholar]
- 4.Janes S M, Mu D, Wemmer D, Smith A J, Kaur S, Maltby D, Burlingame A L, Klinman J P. Science. 1990;248:981–987. doi: 10.1126/science.2111581. [DOI] [PubMed] [Google Scholar]
- 5.Wang S X, Mure M, Medzihradszky K F, Burlingame A L, Brown D E, Dooley D M, Smith A J, Kagan H M, Klinman J P. Science. 1996;273:1078–1084. doi: 10.1126/science.273.5278.1078. [DOI] [PubMed] [Google Scholar]
- 6.Ostermeier C, Harrenga A, Ermler U, Michel H. Proc Natl Acad Sci USA. 1997;94:10547–10553. doi: 10.1073/pnas.94.20.10547. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Yoshikawa S, Shinzawaitoh K, Nakashima R, Yaono R, Yamashita E, Inoue N, Yao M, Fei M J, Libeu C P, Mizushima T, Yamaguchi H, Tomizaki T, Tsukihara T. Science. 1998;280:1723–1729. doi: 10.1126/science.280.5370.1723. [DOI] [PubMed] [Google Scholar]
- 8.Bravo J, Fita I, Ferrer J C, Ens W, Hillar A, Switala J, Loewen P C. Protein Sci. 1997;6:1016–1023. doi: 10.1002/pro.5560060507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ito N, Phillips S E V, Stevens C, Ogel Z B, McPherson M J, Keen J N, Yadav K D S, Knowles P F. Nature (London) 1991;350:87–90. doi: 10.1038/350087a0. [DOI] [PubMed] [Google Scholar]
- 10.Whittaker M M, Whittaker J W. J Biol Chem. 1988;263:6074–6080. [PubMed] [Google Scholar]
- 11.Whittaker M M, Whittaker J W. J Biol Chem. 1990;265:9610–9613. [PubMed] [Google Scholar]
- 12.Itoh S, Takayama S, Arakawa R, Furuta A, Komatsu M, Ishida A, Takamuku S, Fukuzumi S. Inorg Chem. 1997;36:1407–1416. doi: 10.1021/ic961144a. [DOI] [PubMed] [Google Scholar]
- 13.Johnson J M, Halsall H B, Heineman W R. Biochemistry. 1985;24:1579–1585. doi: 10.1021/bi00328a001. [DOI] [PubMed] [Google Scholar]
- 14.Himo F, Eriksson L A, Maseras F, Siegbahn P E M. J Am Chem Soc. 2000;122:8031–8036. [Google Scholar]
- 15.Graichen M E, Jones L H, Sharma B V, van Spanning R J, Hosler J P, Davidson V L. J Bacteriol. 1999;181:4216–4222. doi: 10.1128/jb.181.14.4216-4222.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Szameit C, Miech C, Balleininger M, Schmidt B, von Figura K, Dierks T. J Biol Chem. 1999;274:15375–15381. doi: 10.1074/jbc.274.22.15375. [DOI] [PubMed] [Google Scholar]
- 17.Cai D, Klinman J P. J Biol Chem. 1994;269:32039–32042. [PubMed] [Google Scholar]
- 18.Matsuzaki R, Fukui T, Sato H, Ozaki Y, Tanizawa K. FEBS Lett. 1994;351:360–364. doi: 10.1016/0014-5793(94)00884-1. [DOI] [PubMed] [Google Scholar]
- 19.Ruggiero C E, Smith J A, Tanizawa K, Dooley D M. Biochemistry. 1997;36:1953–1959. doi: 10.1021/bi9628836. [DOI] [PubMed] [Google Scholar]
- 20.Schwede T F, Rétey J, Schulz G E. Biochemistry. 1999;38:5355–5361. doi: 10.1021/bi982929q. [DOI] [PubMed] [Google Scholar]
- 21.Heim R, Prasher D C, Tsien R Y. Proc Natl Acad Sci USA. 1994;91:12501–12504. doi: 10.1073/pnas.91.26.12501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Rogers M S, Baron A J, McPherson M J, Knowles P F, Dooley D M. J Am Chem Soc. 2000;122:990–991. [Google Scholar]
- 23.van Poelje P D, Snell E E. Annu Rev Biochem. 1990;59:29–59. doi: 10.1146/annurev.bi.59.070190.000333. [DOI] [PubMed] [Google Scholar]
- 24.Nagashima S, Nakasako M, Dohmae N, Tsujimura M, Takio K, Odaka M, Yohda M, Kamiya N, Endo I. Nat Struct Biol. 1998;5:347–351. doi: 10.1038/nsb0598-347. [DOI] [PubMed] [Google Scholar]
- 25.Claiborne A, Yeh J I, Mallett T C, Luba J, Crane E J, 3rd, Charrier V, Parsonage D. Biochemistry. 1999;38:15407–15416. doi: 10.1021/bi992025k. [DOI] [PubMed] [Google Scholar]
- 26.Dove J E, Schwartz B, Williams N K, Klinman J P. Biochemistry. 2000;39:3690–3698. doi: 10.1021/bi992225w. [DOI] [PubMed] [Google Scholar]
- 27.Schwartz B, Dove J E, Klinman J P. Biochemistry. 2000;39:3699–3707. doi: 10.1021/bi9922244. [DOI] [PubMed] [Google Scholar]
- 28.Wang Y D, Dubois J L, Hedman B, Hodgson K O, Stack T D P. Science. 1998;279:537–540. doi: 10.1126/science.279.5350.537. [DOI] [PubMed] [Google Scholar]
- 29.Chaudhuri P, Hess M, Florke U, Wieghardt K. Angew Chem Int Ed Engl. 1998;37:2217–2220. doi: 10.1002/(SICI)1521-3773(19980904)37:16<2217::AID-ANIE2217>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
- 30.Jazdzewski B A, Tolman W B. Coord Chem Rev. 2000;200:633–685. [Google Scholar]
- 31.Whittaker M M, Ballou D P, Whittaker J W. Biochemistry. 1998;37:8426–8436. doi: 10.1021/bi980328t. [DOI] [PubMed] [Google Scholar]
- 32.Whittaker M M, Whittaker J W. Biochemistry. 2001;40:7140–7148. doi: 10.1021/bi010303l. [DOI] [PubMed] [Google Scholar]
- 33.Wachter R M, Montaguesmith M P, Branchaud B P. J Am Chem Soc. 1997;119:7743–7749. [Google Scholar]
- 34.Wilmot C M, Murray J M, Alton G, Parsons M R, Convery M A, Blakeley V, Corner A S, Palcic M M, Knowles P F, McPherson M J, Phillips S E. Biochemistry. 1997;36:1608–1620. doi: 10.1021/bi962205j. [DOI] [PubMed] [Google Scholar]